DELTEC ASSET MANAGEMENT LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
DELTEC ASSET MANAGEMENT LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,128,000
+0.6%
460,500
+67.2%
0.17%
+10.4%
Q2 2021$1,121,000
-58.0%
275,500
-53.4%
0.15%
-61.2%
Q1 2021$2,666,000
-21.9%
591,088
-14.8%
0.40%
-24.1%
Q4 2020$3,414,000
-32.5%
693,870
-18.7%
0.52%
-42.2%
Q3 2020$5,059,000
+639.6%
853,132
+231.8%
0.90%
+532.9%
Q2 2020$684,000257,1320.14%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders